A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system

• Main Authors: Mingdi Liu (Author), Liting Gu (Author), Yuning Zhang (Author), Honglan Zhou (Author), Yishu Wang (Author), Zhi-Xiang Xu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Mesalazine, a preparation of 5-aminosalicylic acid, is a medication widely used in clinical practice as a first-line therapy in the treatment of mild and moderate inflammatory bowel disease. However, the long-term safety of mesalazine in large sample population was unknown. The current s...